<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">34840987</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>03</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>28</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">2314-6753</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>2021</Volume>
            <PubDate>
              <Year>2021</Year>
            </PubDate>
          </JournalIssue>
          <Title>Journal of diabetes research</Title>
          <ISOAbbreviation>J Diabetes Res</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Silver Nanoparticles Conjugate Attenuates Highly Active Antiretroviral Therapy-Induced Hippocampal Nissl Substance and Cognitive Deficits in Diabetic Rats.</ArticleTitle>
        <Pagination>
          <StartPage>2118538</StartPage>
          <MedlinePgn>2118538</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">2118538</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1155/2021/2118538</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The application of nanomedicine to antiretroviral drug delivery holds promise in reducing the comorbidities related to long-term systemic exposure to highly active antiretroviral therapy (HAART). However, the safety of drugs loaded with silver nanoparticles has been debatable. This study is aimed at evaluating the effects of HAART-loaded silver nanoparticles (HAART-AgNPs) on the behavioural assessment, biochemical indices, morphological, and morphometric of the hippocampus in diabetic Sprague-Dawley rats.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Conjugated HAART-AgNPs were characterized using FTIR spectroscopy, UV spectrophotometer, HR-TEM, SEM, and EDX for absorbance peaks, size and morphology, and elemental components. Forty-eight male SD rats (250 ± 13 g) were divided into nondiabetic and diabetic groups. Each group was subdivided into (<i>n</i> = 8) A (nondiabetic+vehicle), B (nondiabetic+HAART), C (nondiabetic+HAART-AgNPs), D (diabetic+vehicle), E (diabetic+HAART), and F (diabetic+HAART-AgNPs). Morris water maze, Y-maze test, and weekly blood glucose levels were carried out. Following the last dose of 8-week treatment, the rats were anaesthetized and euthanized. Brain tissues were carefully removed and postfixed for Nissl staining histology.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">1.5 M concentration of HAART-AgNPs showed nanoparticle size 20.3 nm with spherical shape. HAART-AgNPs revealed 16.89% of silver and other elemental components of HAART. The diabetic control rats showed a significant increase in blood glucose, reduced spatial learning, positive hippocampal Nissl-stained cells, and a significant decrease in GSH and SOD levels. However, administration of HAART-AgNPs to diabetic rats significantly reduced blood glucose level, improved spatial learning, biochemical indices, and enhanced memory compared to diabetic control. Interestingly, diabetic HAART-AgNP-treated rats showed a significantly improved memory, increased GSH, SOD, and number of positive Nissl-stained neurons compared to diabetic-treated HAART only.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Administration of HAART to diabetic rats aggravates the complications of diabetes and promotes neurotoxic effects on the experimental rats, while HAART-loaded silver nanoparticle (HAART-AgNP) alleviates diabetes-induced neurotoxicity.</AbstractText>
          <CopyrightInformation>Copyright © 2021 Sodiq Kolawole Lawal et al.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Lawal</LastName>
            <ForeName>Sodiq Kolawole</ForeName>
            <Initials>SK</Initials>
            <Identifier Source="ORCID">0000-0002-8598-4058</Identifier>
            <AffiliationInfo>
              <Affiliation>Discipline of Clinical Anatomy, School of Laboratory Medicine &amp; Medical Sciences, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, 719 Umbilo Road, Durban, South Africa.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Olojede</LastName>
            <ForeName>Samuel Oluwaseun</ForeName>
            <Initials>SO</Initials>
            <Identifier Source="ORCID">0000-0002-1000-7412</Identifier>
            <AffiliationInfo>
              <Affiliation>Discipline of Clinical Anatomy, School of Laboratory Medicine &amp; Medical Sciences, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, 719 Umbilo Road, Durban, South Africa.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dare</LastName>
            <ForeName>Ayobami</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0003-0516-5384</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Physiology, School of Laboratory Medicine &amp; Medical Sciences, Westville Campus, University of KwaZulu-Natal, Durban, South Africa.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Faborode</LastName>
            <ForeName>Oluwaseun Samuel</ForeName>
            <Initials>OS</Initials>
            <Identifier Source="ORCID">0000-0002-2102-0751</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Physiology, School of Laboratory Medicine &amp; Medical Sciences, Westville Campus, University of KwaZulu-Natal, Durban, South Africa.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Naidu</LastName>
            <ForeName>Edwin Coleridge S</ForeName>
            <Initials>ECS</Initials>
            <Identifier Source="ORCID">0000-0002-2691-4017</Identifier>
            <AffiliationInfo>
              <Affiliation>Discipline of Clinical Anatomy, School of Laboratory Medicine &amp; Medical Sciences, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, 719 Umbilo Road, Durban, South Africa.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rennie</LastName>
            <ForeName>Carmen Olivia</ForeName>
            <Initials>CO</Initials>
            <Identifier Source="ORCID">0000-0003-2414-6293</Identifier>
            <AffiliationInfo>
              <Affiliation>Discipline of Clinical Anatomy, School of Laboratory Medicine &amp; Medical Sciences, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, 719 Umbilo Road, Durban, South Africa.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Azu</LastName>
            <ForeName>Onyemaechi Okpara</ForeName>
            <Initials>OO</Initials>
            <Identifier Source="ORCID">0000-0003-0916-7184</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Anatomy, School of Medicine, University of Namibia, Windhoek, Private Bag 13301, Namibia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>19</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>J Diabetes Res</MedlineTA>
        <NlmUniqueID>101605237</NlmUniqueID>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D019380">Anti-HIV Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000068257">Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D018030">Silver Compounds</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019380" MajorTopicYN="N">Anti-HIV Agents</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D023241" MajorTopicYN="N">Antiretroviral Therapy, Highly Active</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001522" MajorTopicYN="N">Behavior, Animal</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D060825" MajorTopicYN="N">Cognitive Dysfunction</DescriptorName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
          <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
          <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003921" MajorTopicYN="N">Diabetes Mellitus, Experimental</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003924" MajorTopicYN="N">Diabetes Mellitus, Type 2</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003929" MajorTopicYN="N">Diabetic Neuropathies</DescriptorName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
          <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
          <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000068257" MajorTopicYN="N">Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006624" MajorTopicYN="N">Hippocampus</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008124" MajorTopicYN="N">Locomotion</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008568" MajorTopicYN="N">Memory</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D053768" MajorTopicYN="Y">Metal Nanoparticles</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000084443" MajorTopicYN="N">Morris Water Maze Test</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009562" MajorTopicYN="N">Nissl Bodies</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018030" MajorTopicYN="N">Silver Compounds</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement>The authors have no conflict of interest to declare.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>8</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>9</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>29</Day>
          <Hour>6</Hour>
          <Minute>32</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>30</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34840987</ArticleId>
        <ArticleId IdType="pmc">PMC8626174</ArticleId>
        <ArticleId IdType="doi">10.1155/2021/2118538</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>American Diabetes Association. Standards of medical care in diabetes--2010. 
Diabetes Care
. 2010;33(Supplement_1):S11–S61. doi: 10.2337/dc10-S011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/dc10-S011</ArticleId>
            <ArticleId IdType="pmc">PMC2797382</ArticleId>
            <ArticleId IdType="pubmed">20042772</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Punthakee Z., Goldenberg R., Katz P. Definition, classification and diagnosis of diabetes, prediabetes and metabolic syndrome. 
Canadian Journal of Diabetes
. 2018;42(Suppl 1):S10–S15. doi: 10.1016/j.jcjd.2017.10.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jcjd.2017.10.003</ArticleId>
            <ArticleId IdType="pubmed">29650080</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bam N. E., Mabunda S. A., Ntsaba J., Apalata T., Nomatshila S. C., Chitha W. The association between HIV tri-therapy with the development of type-2 diabetes mellitus in a rural South African district: a case-control study. 
PLoS One
. 2020;15(12, article e0244067) doi: 10.1371/journal.pone.0244067.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0244067</ArticleId>
            <ArticleId IdType="pmc">PMC7775046</ArticleId>
            <ArticleId IdType="pubmed">33382732</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meintjes G., Moorhouse M. A., Carmona S., et al.  Adult antiretroviral therapy guidelines 2017. 
Southern African journal of HIV medicine
. 2017;18(1):p. 776. doi: 10.4102/sajhivmed.v18i1.776.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4102/sajhivmed.v18i1.776</ArticleId>
            <ArticleId IdType="pmc">PMC5843236</ArticleId>
            <ArticleId IdType="pubmed">29568644</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mannu C., Songini M. Brain diabetes: the new type 3 diabetes. 
Diabetes Case Reports
. 2018;3(2) doi: 10.4172/2572-5629.1000e104.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4172/2572-5629.1000e104</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chandrasekaran K., Choi J., Arvas M. I., et al.  Nicotinamide mononucleotide administration prevents experimental diabetes-induced cognitive impairment and loss of hippocampal neurons. 
International Journal of Molecular Sciences
. 2020;21(11):p. 3756. doi: 10.3390/ijms21113756.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms21113756</ArticleId>
            <ArticleId IdType="pmc">PMC7313029</ArticleId>
            <ArticleId IdType="pubmed">32466541</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McCrimmon R. J., Ryan C. M., Frier B. M. Diabetes and cognitive dysfunction. 
Lancet
. 2012;379(9833):2291–2299. doi: 10.1016/S0140-6736(12)60360-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(12)60360-2</ArticleId>
            <ArticleId IdType="pubmed">22683129</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Teixeira M. M., Passos V. M. A., Barreto S. M., et al.  Association between diabetes and cognitive function at baseline in the Brazilian Longitudinal Study of Adult Health (ELSA- Brasil) 
Scientific Reports
. 2020;10(1):p. 1596. doi: 10.1038/s41598-020-58332-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-020-58332-9</ArticleId>
            <ArticleId IdType="pmc">PMC6994611</ArticleId>
            <ArticleId IdType="pubmed">32005901</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maartens G., Celum C., Lewin S. R. HIV infection: epidemiology, pathogenesis, treatment, and prevention. 
The Lancet
. 2014;384(9939):258–271. doi: 10.1016/S0140-6736(14)60164-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(14)60164-1</ArticleId>
            <ArticleId IdType="pubmed">24907868</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gazzard B., De Jesus E., Campo R., et al.  The combination of tenofovir DF (TDF), emtricitabine (FTC) and efavirenz (EFV) has significantly greater response vs fixed dose zidovudine/lamivudine (CBV) and EFV in antiretroviral naive patients: a 24 week preliminary analysis. 44th Interscience Conference on Antimicrobial Agents and Chemotherapy; 2004; Washington, USA. </Citation>
        </Reference>
        <Reference>
          <Citation>Costagliola D. Demographics of HIV and aging. 
Current Opinion in HIV and AIDS
. 2014;9(4):294–301. doi: 10.1097/COH.0000000000000076.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/COH.0000000000000076</ArticleId>
            <ArticleId IdType="pubmed">24824889</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>d’Ettorre G., Ceccarelli G., Pavone P., et al.  What happens to cardiovascular system behind the undetectable level of HIV viremia? 
AIDS Research and Therapy
. 2016;13(1):p. 21. doi: 10.1186/s12981-016-0105-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12981-016-0105-z</ArticleId>
            <ArticleId IdType="pmc">PMC4848790</ArticleId>
            <ArticleId IdType="pubmed">27127532</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nduka C., Sarki A., Uthman O., Stranges S. Impact of antiretroviral therapy on serum lipoprotein levels and dyslipidemias: a systematic review and meta-analysis. 
International Journal of Cardiology
. 2015;199:307–318. doi: 10.1016/j.ijcard.2015.07.052.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijcard.2015.07.052</ArticleId>
            <ArticleId IdType="pubmed">26241636</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tshikuka J. G., Rankgoane-Pono G., Magafu M., et al.  Relationship between combination antiretroviral therapy regimens and diabetes mellitus-related comorbidities among HIV patients in Gaborone Botswana. 
BMC Public Health
. 2018;18(1):p. 464. doi: 10.1186/s12889-018-5232-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12889-018-5232-0</ArticleId>
            <ArticleId IdType="pmc">PMC5891989</ArticleId>
            <ArticleId IdType="pubmed">29631557</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Naidu E. C. S., Olojede S. O., Lawal S. K., Rennie C. O., Azu O. O. Nanoparticle delivery system, highly active antiretroviral therapy, and testicular morphology: the role of stereology. 
Pharmacology Research &amp; Perspectives
. 2021;9(3, article e00776) doi: 10.1002/prp2.776.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/prp2.776</ArticleId>
            <ArticleId IdType="pmc">PMC8189564</ArticleId>
            <ArticleId IdType="pubmed">34107163</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Avari P., Devendra S. Human immunodeficiency virus and type 2 diabetes. 
London journal of primary care
. 2017;9(3):38–42. doi: 10.1080/17571472.2017.1302872.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/17571472.2017.1302872</ArticleId>
            <ArticleId IdType="pmc">PMC5434564</ArticleId>
            <ArticleId IdType="pubmed">28539977</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hulgan T., Morrow J., D'Aquila R. T., et al.  Oxidant stress is increased during treatment of human immunodeficiency virus infection. 
Clinical Infectious Diseases
. 2003;37(12):1711–1717. doi: 10.1086/379776.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/379776</ArticleId>
            <ArticleId IdType="pubmed">14689356</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nsonwu-Anyanwu A., Ighodalo E., King D., et al.  Biomarkers of oxidative stress in HIV seropositive individuals on highly active antiretroviral therapy. 
Reactive Oxygen Species
. 2017;3(9):1–11. doi: 10.20455/ros.2017.827.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.20455/ros.2017.827</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sharma B. Oxidative stress in HIV patients receiving antiretroviral therapy. 
Current HIV Research
. 2014;12(1):13–21. doi: 10.2174/1570162X12666140402100959.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/1570162X12666140402100959</ArticleId>
            <ArticleId IdType="pubmed">24694264</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin S. P., Wu C. Y., Wang C. B., Li T. C., Ko N. Y., Shi Z. Y. Risk of diabetes mellitus in HIV-infected patients receiving highly active antiretroviral therapy: a nationwide population-based study. 
Medicine (Baltimore)
. 2018;97(36, article e12268) doi: 10.1097/MD.0000000000012268.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MD.0000000000012268</ArticleId>
            <ArticleId IdType="pmc">PMC6133418</ArticleId>
            <ArticleId IdType="pubmed">30200166</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lucas S. B., Zaki S. R., Portmann B. C.  
MacSween’s Pathology of the Liver 2012
. 6th. Philadelphia: Pennsylvania Churchill Livingstone; 2011. Other viral and infectious diseases and HIV-related liver disease; pp. 403–466.</Citation>
        </Reference>
        <Reference>
          <Citation>Anand K. S., Dhikav V. Hippocampus in health and disease: an overview. 
Annals of Indian Academy of Neurology
. 2012;15(4):239–246. doi: 10.4103/0972-2327.104323.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4103/0972-2327.104323</ArticleId>
            <ArticleId IdType="pmc">PMC3548359</ArticleId>
            <ArticleId IdType="pubmed">23349586</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang X., Michaelis E. Selective neuronal vulnerability to oxidative stress in the brain. 
Frontiers in Aging Neuroscience
. 2010;2(12)</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2874397</ArticleId>
            <ArticleId IdType="pubmed">20552050</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Patra J. K., Das G., Fraceto L. F., et al.  Nano based drug delivery systems: recent developments and future prospects. 
Journal of nanobiotechnology
. 2018;16(1):p. 71. doi: 10.1186/s12951-018-0392-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12951-018-0392-8</ArticleId>
            <ArticleId IdType="pmc">PMC6145203</ArticleId>
            <ArticleId IdType="pubmed">30231877</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cojocaru F. D., Botezat D., Gardikiotis I., et al.  Nanomaterials designed for antiviral drug delivery transport across biological barriers. 
Pharmaceutics
. 2020;12(2):p. 171. doi: 10.3390/pharmaceutics12020171.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/pharmaceutics12020171</ArticleId>
            <ArticleId IdType="pmc">PMC7076512</ArticleId>
            <ArticleId IdType="pubmed">32085535</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rohan L. Progress in antiretroviral drug delivery using nanotechnology. 
International Journal of Nanomedicine
. 2010;5:p. 533. doi: 10.2147/IJN.S7681.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/IJN.S7681</ArticleId>
            <ArticleId IdType="pmc">PMC2950411</ArticleId>
            <ArticleId IdType="pubmed">20957115</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mahajan S. D., Aalinkeel R., Law W. C., et al.  Anti-HIV-1 nanotherapeutics: promises and challenges for the future. 
International Journal of Nanomedicine
. 2012;7:5301–5314. doi: 10.2147/IJN.S25871.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/IJN.S25871</ArticleId>
            <ArticleId IdType="pmc">PMC3468275</ArticleId>
            <ArticleId IdType="pubmed">23055735</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marin S., Vlasceanu G., Tiplea R., et al.  Applications and toxicity of silver nanoparticles: a recent review. 
Current topics in medicinal chemistry
. 2015;15(16):1596–1604. doi: 10.2174/1568026615666150414142209.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/1568026615666150414142209</ArticleId>
            <ArticleId IdType="pubmed">25877089</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vadlapudi V., Amanchy R. Phytofabrication of silver nanoparticles using Myriostachya wightiana as a novel bioresource, and evaluation of their biological activities. 
Brazilian Archives of Biology and Technology
. 2017;60 doi: 10.1590/1678-4324-2017160329.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1590/1678-4324-2017160329</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Turkevich J., Stevenson P. C., Hillier J. A study of the nucleation and growth processes in the synthesis of colloidal gold. 
Discussions of the Faraday Society
. 1951;11:55–75. doi: 10.1039/df9511100055.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1039/df9511100055</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smurzynski M., Wu K., Letendre S., et al.  Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort. 
AIDS
. 2011;25(3):357–365. doi: 10.1097/QAD.0b013e32834171f8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/QAD.0b013e32834171f8</ArticleId>
            <ArticleId IdType="pmc">PMC3022370</ArticleId>
            <ArticleId IdType="pubmed">21124201</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wilson R. D., Islam M. S. Fructose-fed streptozotocin-injected rat: an alternative model for type 2 diabetes. 
Pharmacological Reports
. 2012;64(1):129–139. doi: 10.1016/S1734-1140(12)70739-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1734-1140(12)70739-9</ArticleId>
            <ArticleId IdType="pubmed">22580529</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Everson F., Genis A., Ogundipe T., et al.  Treatment with a fixed dose combination antiretroviral therapy drug containing tenofovir, emtricitabine and efavirenz is associated with cardioprotection in high calorie diet-induced obese rats. 
PLoS One
. 2018;13(12, article e0208537) doi: 10.1371/journal.pone.0208537.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0208537</ArticleId>
            <ArticleId IdType="pmc">PMC6281242</ArticleId>
            <ArticleId IdType="pubmed">30517206</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Greish K., Alqahtani A. A., Alotaibi A. F., et al.  The effect of silver nanoparticles on learning, memory and social interaction in BALB/C mice. 
International Journal of Environmental Research and Public Health
. 2019;16(1):p. 148. doi: 10.3390/ijerph16010148.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijerph16010148</ArticleId>
            <ArticleId IdType="pmc">PMC6339045</ArticleId>
            <ArticleId IdType="pubmed">30625980</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. 
Journal of Neuroscience Methods
. 1984;11(1):47–60. doi: 10.1016/0165-0270(84)90007-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0165-0270(84)90007-4</ArticleId>
            <ArticleId IdType="pubmed">6471907</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hughes R. N. The value of spontaneous alternation behavior (SAB) as a test of retention in pharmacological investigations of memory. 
Neuroscience and Biobehavioral Reviews
. 2004;28(5):497–505. doi: 10.1016/j.neubiorev.2004.06.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neubiorev.2004.06.006</ArticleId>
            <ArticleId IdType="pubmed">15465137</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Typlt M., Mirkowski M., Azzopardi E., Ruettiger L., Ruth P., Schmid S. Mice with deficient BK channel function show impaired prepulse inhibition and spatial learning, but normal working and spatial reference memory. 
PLoS One
. 2013;8(11, article e81270) doi: 10.1371/journal.pone.0081270.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0081270</ArticleId>
            <ArticleId IdType="pmc">PMC3841135</ArticleId>
            <ArticleId IdType="pubmed">24303038</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ellman G. L. Tissue sulfhydryl groups. 
Archives of biochemistry and biophysics
. 1959;82(1):70–77. doi: 10.1016/0003-9861(59)90090-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0003-9861(59)90090-6</ArticleId>
            <ArticleId IdType="pubmed">13650640</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kakkar P., Das B., Viswanathan P. N. A modified spectrophotometric assay of superoxide dismutase. 
Indian Journal of Biochemistry &amp; Biophysics
. 1984;21(2):130–132.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6490072</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mkhwanazi B. N., Serumula M. R., Myburg R. B., Van Heerden F. R., Musabayane C. T. Antioxidant effects of maslinic acid in livers, hearts and kidneys of streptozotocin-induced diabetic rats: effects on kidney function. 
Renal Failure
. 2014;36(3):419–431. doi: 10.3109/0886022X.2013.867799.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/0886022X.2013.867799</ArticleId>
            <ArticleId IdType="pubmed">24344651</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gu J. X., Cheng X. J., Luo X., et al.  Luteolin ameliorates cognitive impairments by suppressing the expression of inflammatory cytokines and enhancing synapse-associated proteins GAP-43 and SYN levels in streptozotocin-induced diabetic rats. 
Neurochemical Research
. 2018;43(10):1905–1913. doi: 10.1007/s11064-018-2608-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11064-018-2608-6</ArticleId>
            <ArticleId IdType="pubmed">30088237</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Michaud V., Bar-Magen T., Turgeon J., Flockhart D., Desta Z., Wainberg M. A. The dual role of pharmacogenetics in HIV treatment: mutations and polymorphisms regulating antiretroviral drug resistance and disposition. 
Pharmacological Reviews
. 2012;64(3):803–833. doi: 10.1124/pr.111.005553.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1124/pr.111.005553</ArticleId>
            <ArticleId IdType="pubmed">22759796</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>ECDL G., Mussel W. N., Resende J. M., Fialho S. L., Barbosa J., Yoshida M. I. Chemical interactions study of antiretroviral drugs efavirenz and lamivudine concerning the development of stable fixed-dose combination formulations for AIDS treatment. 
Journal of the Brazilian Chemical Society
. 2013;24 doi: 10.5935/0103-5053.20130071.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5935/0103-5053.20130071</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>la Spina R., Mehn D., Fumagalli F., et al.  Synthesis of citrate-stabilized silver nanoparticles modified by thermal and pH preconditioned tannic acid. 
Nanomaterials
. 2020;10(10):p. 2031. doi: 10.3390/nano10102031.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/nano10102031</ArticleId>
            <ArticleId IdType="pmc">PMC7602624</ArticleId>
            <ArticleId IdType="pubmed">33076398</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yerragopu P. S., Hiregoudar S., Nidoni U., Ramappa K. T., Sreenivas A. G., Doddagoudar S. R. Chemical synthesis of silver nanoparticles using tri-sodium citrate, stability study and their characterization. 
International Research Journal of Pure and Applied Chemistry
. 2020;21(3):37–50. doi: 10.9734/irjpac/2020/v21i330159.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.9734/irjpac/2020/v21i330159</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jyoti K., Baunthiyal M., Singh A. Characterization of silver nanoparticles synthesized usingUrtica dioicaLinn. leaves and their synergistic effects with antibiotics. 
Journal of Radiation Research and Applied Sciences
. 2016;9(3):217–227. doi: 10.1016/j.jrras.2015.10.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jrras.2015.10.002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Agnihotri S., Mukherji S., Mukherji S. Size-controlled silver nanoparticles synthesized over the range 5–100 nm using the same protocol and their antibacterial efficacy. 
RSC Advances
. 2014;4(8):3974–3983. doi: 10.1039/C3RA44507K.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1039/C3RA44507K</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Femi-Adepoju A. G., Dada A. O., Otun K. O., Adepoju A. O., Fatoba O. P. Green synthesis of silver nanoparticles using terrestrial fern (Gleichenia pectinata (Willd.) C. Presl.): characterization and antimicrobial studies. 
Heliyon
. 2019;5(4, article e01543)</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6479216</ArticleId>
            <ArticleId IdType="pubmed">31049445</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brown T. T., Cole S. R., Li X., et al.  Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. 
Archives of Internal Medicine
. 2005;165(10):1179–1184. doi: 10.1001/archinte.165.10.1179.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/archinte.165.10.1179</ArticleId>
            <ArticleId IdType="pubmed">15911733</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Madugulla L., Ravula A. R., Kondapi A. K., Yenugu S. Evaluation of the reproductive toxicity of antiretroviral drug loaded lactoferrin nanoparticles. 
Systems Biology in Reproductive Medicine
. 2019;65(3):205–213. doi: 10.1080/19396368.2018.1519047.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/19396368.2018.1519047</ArticleId>
            <ArticleId IdType="pubmed">30260720</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ogunwuyi O., Kumari N., Smith K. A., et al.  Antiretroviral drugs-loaded nanoparticles fabricated by dispersion polymerization with potential for HIV/AIDS treatment. 
Infectious Diseases: Research and Treatment
. 2016;9, article 21:32.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4803317</ArticleId>
            <ArticleId IdType="pubmed">27013886</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maganga E., Smart L. R., Kalluvya S., et al.  Glucose metabolism disorders, HIV and antiretroviral therapy among Tanzanian adults. 
PLoS One
. 2015;10(8, article e0134410) doi: 10.1371/journal.pone.0134410.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0134410</ArticleId>
            <ArticleId IdType="pmc">PMC4545793</ArticleId>
            <ArticleId IdType="pubmed">26287742</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alkaladi A., Abdelazim A. M., Afifi M. Antidiabetic activity of zinc oxide and silver nanoparticles on streptozotocin-induced diabetic rats. 
International Journal of Molecular Sciences
. 2014;15(2):2015–2023. doi: 10.3390/ijms15022015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms15022015</ArticleId>
            <ArticleId IdType="pmc">PMC3958835</ArticleId>
            <ArticleId IdType="pubmed">24477262</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alford K., Vera J. H. Cognitive impairment in people living with HIV in the ART era: a review. 
British Medical Bulletin
. 2018;127(1):55–68. doi: 10.1093/bmb/ldy019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/bmb/ldy019</ArticleId>
            <ArticleId IdType="pubmed">29868901</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ellis R. J., Letendre S., Vaida F., et al.  Randomized trial of central nervous system-targeted antiretrovirals for HIV-associated neurocognitive disorder. 
Clinical Infectious Diseases
. 2014;58(7):1015–1022. doi: 10.1093/cid/cit921.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cid/cit921</ArticleId>
            <ArticleId IdType="pmc">PMC3952601</ArticleId>
            <ArticleId IdType="pubmed">24352352</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kumar P., Lakshmi Y. S., Kondapi A. K. Triple drug combination of zidovudine, efavirenz and lamivudine loaded lactoferrin nanoparticles: an effective nano first-line regimen for HIV therapy. 
Pharmaceutical Research
. 2017;34(2):257–268. doi: 10.1007/s11095-016-2048-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11095-016-2048-4</ArticleId>
            <ArticleId IdType="pubmed">27928647</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cohen R. A., Harezlak J., Schifitto G., et al.  Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era. 
Journal of Neurovirology
. 2010;16(1):25–32. doi: 10.3109/13550280903552420.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/13550280903552420</ArticleId>
            <ArticleId IdType="pmc">PMC2995252</ArticleId>
            <ArticleId IdType="pubmed">20113183</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Akang E. N. Combination antiretroviral therapy (cART)-induced hippocampal disorders: highlights on therapeutic potential of naringenin and quercetin. 
IBRO reports
. 2019;6:137–146. doi: 10.1016/j.ibror.2019.04.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ibror.2019.04.002</ArticleId>
            <ArticleId IdType="pmc">PMC6488719</ArticleId>
            <ArticleId IdType="pubmed">31061913</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iorjiim W. M., Omale S., Etuh M. A., Bagu G. D., Ogwu S. O., Gyang S. S. EFVb-HAART increases mortality, locomotor deficits and reduces reproductive capacity in Drosophila melanogaster. 
Journal of Advances in Biology &amp; Biotechnology
. 2020;23(1):26–38. doi: 10.9734/jabb/2020/v23i130136.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.9734/jabb/2020/v23i130136</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ichiishi E., Li X. K., Iorio E. L. Oxidative stress and diseases: clinical trials and approaches. 
Oxidative Medicine and Cellular Longevity
. 2016;2016:3. doi: 10.1155/2016/3458276.3458276</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2016/3458276</ArticleId>
            <ArticleId IdType="pmc">PMC5090085</ArticleId>
            <ArticleId IdType="pubmed">27833701</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wilde G. J., Pringle A. K., Wright P., Iannotti F. Differential vulnerability of the CA1 and CA3 subfields of the hippocampus to superoxide and hydroxyl radicals in vitro. 
Journal of Neurochemistry
. 1997;69(2):883–886. doi: 10.1046/j.1471-4159.1997.69020883.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.1471-4159.1997.69020883.x</ArticleId>
            <ArticleId IdType="pubmed">9231752</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ngondi J. L., Oben J., Forkah D. M., Etame L. H., Mbanya D. The effect of different combination therapies on oxidative stress markers in HIV infected patients in Cameroon. 
AIDS Research and Therapy
. 2006;3(1):p. 19. doi: 10.1186/1742-6405-3-19.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1742-6405-3-19</ArticleId>
            <ArticleId IdType="pmc">PMC1557529</ArticleId>
            <ArticleId IdType="pubmed">16859567</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Williams A. A., Sitole L. J., Meyer D. HIV/HAART-associated oxidative stress is detectable by metabonomics. 
Molecular BioSystems
. 2017;13(11):2202–2217. doi: 10.1039/C7MB00336F.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1039/C7MB00336F</ArticleId>
            <ArticleId IdType="pubmed">28920117</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Honigsperger C., Marosi M., Murphy R., Storm J. F. Dorsoventral differences in Kv7/M-current and its impact on resonance, temporal summation and excitability in rat hippocampal pyramidal cells. 
The Journal of Physiology
. 2015;593(7):1551–1580. doi: 10.1113/jphysiol.2014.280826.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1113/jphysiol.2014.280826</ArticleId>
            <ArticleId IdType="pmc">PMC4386960</ArticleId>
            <ArticleId IdType="pubmed">25656084</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Akinola O. B., Omotoso O. G., Dosumu O. O., Akinola O. S., Olotufore F. Diabetes-induced prefrontal Nissl substance deficit and the effects of neem-bitter leaf extract treatment. 
International Journal of Morphology
. 2011;29(3):850–856. doi: 10.4067/S0717-95022011000300031.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4067/S0717-95022011000300031</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aski M. L., Rezvani M. E., Khaksari M., et al.  Neuroprotective effect of berberine chloride on cognitive impairment and hippocampal damage in experimental model of vascular dementia. 
Iranian Journal of Basic Medical Sciences
. 2018;21(1):53–58. doi: 10.22038/IJBMS.2017.23195.5865.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.22038/IJBMS.2017.23195.5865</ArticleId>
            <ArticleId IdType="pmc">PMC5776437</ArticleId>
            <ArticleId IdType="pubmed">29372037</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mohanta Y. K., Panda S. K., Jayabalan R., Sharma N., Bastia A. K., Mohanta T. K. Antimicrobial, antioxidant and cytotoxic activity of silver nanoparticles synthesized by leaf extract of Erythrina suberosa (Roxb.) 
Frontiers in molecular biosciences
. 2017;4:p. 14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5355429</ArticleId>
            <ArticleId IdType="pubmed">28367437</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
